Task: Answer the multiple-choice question.
Query: Which drug exhibits a 9.913% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a: Cc1ccc2c(c1)N(C(=O)CCC(=O)N1CCC(C(N)=O)CC1)CC(C)O2
b: O=C(COC(=O)Cc1ccc(F)cc1)Nc1ccc(Cl)cn1
c: O=C(O)c1ccc(Br)c(S(=O)(=O)N2CCCC2)c1
Answer: c. O=C(O)c1ccc(Br)c(S(=O)(=O)N2CCCC2)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(O)c1ccc(Br)c(S(=O)(=O)N2CCCC2)c1
O=C(O)c1ccc(Br)c(S(=O)(=O)N2CCCC2)c1
4-bromo-3-pyrrolidin-1-ylsulfonylbenzoic acid